A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19

Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19

NCT04551768 ·Status: COMPLETED ·Phase: PHASE1

SLV213 Treatment in Ambulatory COVID-19 Patients

NCT04843787 ·Status: UNKNOWN ·Phase: PHASE2

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

NCT05445934 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine

NCT05067933 ·Status: TERMINATED ·Phase: PHASE2

Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19

NCT05365321 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780281 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19

NCT04738175 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19

NCT04380961 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19

NCT04576728 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19_#2

NCT04356677 ·Status: WITHDRAWN ·Phase: PHASE1

Baricitinib Compared to Standard Therapy in Patients With COVID-19

NCT04393051 ·Status: UNKNOWN ·Phase: PHASE2

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

NCT07169318 ·Status: RECRUITING ·Phase: PHASE1

MP1032 Treatment in Patients With Moderate to Severe COVID-19

NCT04932941 ·Status: COMPLETED ·Phase: PHASE2

VIR-7831 for the Early Treatment of COVID-19 in Outpatients

NCT04545060 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

NCT05785390 ·Status: TERMINATED ·Phase: PHASE2

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

NCT06679140 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19

NCT04701502 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of SLV213 for the Treatment of COVID-19.

NCT06146374 ·Status: TERMINATED ·Phase: PHASE1

Intravenous Zotatifin in Adults With Mild or Moderate COVID-19

NCT04632381 ·Status: COMPLETED ·Phase: PHASE1

Study of VIR-2482 in Healthy Volunteers

NCT04033406 ·Status: COMPLETED ·Phase: PHASE1

Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness

NCT05689034 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19

NCT05633433 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic

NCT04331834 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19

NCT04779879 ·Status: COMPLETED ·Phase: PHASE2